Clinical Trial Update: Isoniazid-Related Hepatotoxicity in Clinical Practice: Incidence and Predictors

View source ↗

Summary

A clinical trial update assessing the incidence and predictors of isoniazid-related hepatotoxicity in TB infection, including latent TB infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Latent Tuberculosis Infection
• Tuberculosis

Drugs mentioned

• ISONIAZID (ISONIAZID)

Snippet

Sponsor: ASST Fatebenefratelli Sacco | Conditions: Tuberculosis Infection, Tuberculosis Infection, Latent | Status: NOT_YET_RECRUITING